The Operating Theatre Journal - Flipbook - Page 27
INTUBATION CHECKLIST & SAFETY CARDS
Since 2018, the checklist card concept has been an established
patient safety tool, overcoming both physical and institutional
barriers to checklist availability. Carried by doctors, acute area
nurses and ODPs, there are over 13,000 in use worldwide.
•
•
•
Adult checklist card: Utilising Difficult Airway Society
guidelines, and endorsed by key UK bodies (35p each)
Paediatric checklist & safety card: Intubation checklist and
reference sheet for drug dosing and equipment sizing (65p
each)
Global Anaesthetic Safety (GAS) Card: For remote and low &
middle income country (LMIC) use (currently available
through SAFE courses only).
Ordering cards:
Please email Dr Sam Goodhand at checklistcard@outlook.com
with the following details. Please note P&P is £4-10 depending
on order size:
Ø Your name
Ø Your delivery address (home recommended)
Ø Number of cards (minimum 20)
Ø Your hospital or trust
HypnoVR acquires Oncomfort
This strategic takeover con昀椀rms HypnoVR’s position as Europe’s leading
provider of virtual reality-based digital therapies to treat pain and
anxiety, with solutions deployed in more than 550 hospitals
Synergies with Oncomfort will broaden HypnoVR’s product range,
expand its client base and strengthen its patent portfolio, as well as
providing a 昀椀rm foothold in Belgium
HypnoVR plans to increase its European and international presence
with the market release of second-generation machine learning-based
biofeedback digital therapies in 2024
HypnoVR, pioneer and European leader in digital therapies to manage
pain and anxiety, today announces it has acquired Belgian company
Oncomfort, the inventor of Digital Sedation™, a pharmacological
method of relieving patients’ pain and anxiety. The 昀椀nancial terms of
the agreement have not been disclosed.
This acquisition strengthens HypnoVR’s position as the European
leader in digital therapies for pain and anxiety and should speed up
the commercial roll-out of its solutions in Europe. Over 550 European
healthcare facilities are now using HypnoVR technology, including more
than one hundred in Belgium. A total of 200,000 patients have already
been treated using its digital therapies that include software and a
VR headset. The company has the most advanced clinical validation in
its 昀椀eld, with more than 昀椀fty clinical trials having demonstrated the
ef昀椀cacy of the HypnoVR and Oncomfort therapies to manage pain and
anxiety, reduce medication use and improve the care pathway.
“Both HypnoVR and Oncomfort are pioneering companies in digital
sedation and have been built on shared values, scienti昀椀c validation
and strict adherence to regulations to ensure compliance with the
requirements for digital medical devices.
I 昀椀rmly believe that our acquisition by HypnoVR will create worthwhile
collaborations to help healthcare professionals go further in adopting
this solution as the standard of care for relieving pain and anxiety,
bene昀椀ting a growing number of patients,” said Diane Jooris, founder
of Oncomfort.
HypnoVR has a subsidiary in Basel, Switzerland and has just opened an
of昀椀ce in Belgium, where a number of Oncomfort staff will be based.
HypnoVR has advanced, ambitious R&D projects in progress, including
the development of a next-generation therapeutic virtual reality
solution with biofeedback. This system offers a real-time virtual
hypnosedation session adapted to the patient’s physiological condition.
Patents are being 昀椀led to protect its intellectual property. Secondgeneration products are expected to reach the market in 2024.
www.hypnovr.io
“The Oncomfort acquisition is a highly strategic step for HypnoVR that
reinforces our position as the European leader in digital therapies
to treat pain and anxiety and provides an ever-increasing number
of healthcare facilities and patients with access to these advanced
technologies. Our vision is one that Oncomfort shares, based on the
clinical validity of digital therapeutic solutions and the potential of
technology to deliver them to as many people as possible. HypnoVR
pioneered the development and roll-out of virtual reality-based medical
hypnosis solutions in France and Europe, and we intend to ramp up this
work on an international scale,” said Nicolas Schaettel, president and
co-founder of HypnoVR.
Oncomfort was founded in 2017 to develop Digital Sedation™, an
innovative medical device combining the capabilities of virtual reality
with expertise in medical hypnosis. Digital Sedation™ is a CE-marked
product designed to offer patients an alternative or supplementary
treatment to drugs, for managing pain and anxiety.
Find out more 02921 680068 • e-mail admin@lawrand.com
Issue 397
October
2023
27